IME
IMEXHS FPO [IME]
Healthcare · ASX Small Cap
$0.4000 +0.0%
Updated 26 Mar 2026 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +11First seen: 2026-02-27
Score Breakdown
Technical62
Catalyst50
Sentiment50
Fundamental88
Momentum69
Risk Gate35
Get alerts when IME's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- MACD just crossed bullish — momentum is shifting to the upside
- Volume surging at 49.7x normal while price falls — heavy selling pressure
- Trading above the 200-day average — the long-term trend is on your side
- Cash positive / operating cashflow positive
- Low P/S ratio (0.7x)
- Strong revenue growth (+21%)
- EPS estimates revised upward (+10pts)
- Small-cap ($20-100M)
- CANSLIM S: Tight float (48%)
- Sentiment is mixed — no strong consensus either way
- Positive long-term momentum — up 36% over the past year
- The bigger volume days are the up days — volume-weighted momentum is positive (1.09%/day)
- Liquidity risk: 10 zero-volume days in last 20
- Beneish M-Score -2.13 (grey zone -2.22 to -1.78): possible earnings manipulation
- RBA hiking (-3pts)
Risk Signals
- Negative profit margins (-10%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about IME
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Appendix 4G - Feb-26
NONE Corporate Governance Statement - Feb-26
NONE IMEXHS Reports FY25 Results
LOW IMEXHS FY25 Investor Presentation
LOW Appendix 4E & Annual Report 2025
Recent ASX Announcements
| 2026-02-26 | Appendix 4G - Feb-26 |
| 2026-02-26 | Corporate Governance Statement - Feb-26 |
| 2026-02-26 | IMEXHS FY25 Investor Presentation PRICE SENSITIVE |
| 2026-02-26 | IMEXHS Reports FY25 Results PRICE SENSITIVE |
| 2026-02-26 | Appendix 4E & Annual Report 2025 PRICE SENSITIVE |
Key Metrics
$21.6M
Market Cap
27K
Avg Volume
49.7x
Vol Ratio
$0.22 — $0.47
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-19.0%
ROE
-9.9%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 48% |
| L | Leader vs Laggard | laggard | RS: 0 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #32 of 117 · Sector avg: 46
View all Healthcare signals →Track IME and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required